跳至主要内容
临床试验/ACTRN12615000619549
ACTRN12615000619549已完成未知

Dexamphetamine effects on healthy volunteers in a cross-over design on the perceptions of visually, auditory, tactile and multimodal illusions

Mathew Martin-Iverson0 个研究点目标入组 66 人开始时间: 2015年6月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 59 Years(—)
性别
All

入选标准

  • Healthy people >17 and <60 years of age

排除标准

  • 1.Heart or severe blood vessel disease,
  • 2.High blood pressure (> 180/90 mm Hg),
  • 3.Glaucoma,
  • 4.Hyperthyroidism (overactive thyroid),
  • 5.Tics (muscle twitching usually in the face or shoulders),
  • 6.Sensitivity to dexamphetamine or sympathomimetic amines,
  • 7.Any degenerative disease of the nervous system,
  • 8.Epilepsy, or other neurological disorder, including head injury.
  • 9.Tourette's syndrome or a family history of this disorder,
  • 10.A psychiatric or psychological problem for which they are receiving treatment (schizophrenia, depression, anxiety, etc),
  • 11.A serious medical problem for which they are receiving treatment (cardiovascular disorders, respiratory disorders, etc),
  • 12.Had or are currently receiving treatment for substance abuse,
  • 13.A family history of schizophrenia in first-degree relatives (parents, children or siblings),
  • 14.Previously experienced hypersensitivity to dexamphet-amine,
  • 15.Used any drug including alcohol or any illicit drug within 24 hours of each testing session,
  • 16.Used caffeine on the day of each testing session,
  • 17.Current prescription medication that you are taking other than contraceptives or acne medication
  • 18.Used over-the-counter medication in the 48 hours before each testing session

研究者

发起方
Mathew Martin-Iverson

相似试验